News

The Dana-Farber Cancer Institute, the Massachusetts General Hospital, the University of North Carolina at Chapel Hill, and The University of Texas Southwestern Medical Center jointly own the patent

The collaboration will focus on evaluating MCHC’s closed hydroponic cultivation system, plant factory system, developed to grow plants. Medicago’s technologies will be used to produce Nicotiana Benthamiana plants

The $20m new eco-friendly building plant provides space for two new cleanrooms for filter and bag manufacture, labs and offices. Using harvested rainwater and air-handling unit condensate for

The Centricity Practice Solution 11 solution, which features a dynamic search engine, simplifies the data entry required for ambulatory practices to comply with new the ICD-10 coding requirements

Various studies demonstrated a woman’s ability to recognize OAB symptoms, understand vital safety information on the label, judge the necessity of the product use and fittingly use Oxytrol

European patent covers a chemical structure and new chemical process of the chemistry platform technology, developed for therapeutic and cosmetic purpose. Sirona Biochem chief executive officer Neil Belenkie

Desloratadine ODT is a generic equivalent to Clarinex Reditabs (desloratadine), which according to IMS Health data had total sales of $5.3m in the US for the twelve months

Takeda expects to launch the type 2 diabetes therapies as adjuncts to diet and exercise in the summer of 2013. Takeda Pharmaceuticals USA president Douglas Cole said, "Takeda

The single dose Pneumococcal 13-valent conjugate vaccine [Diphtheria CRM197 Protein] will provide protection from invasive disease caused by 13 Streptococcus pneumoniae serotypes. Pfizer vaccine president Susan Silbermann said,